journal article·2026-08Open access

Harnessing the sparing effect of FLASH-RT: From phenomenon observation, radiophysical determinants to molecular mechanisms and synergistic strategies

Zhihui Dou, Huiwen Lei, Jingfen Yang, MengYao Li, Shuting Wang, Xingting Bao, Li Ma, Jinjiang Li, Yong Yin, Tianyuan Dai

Abstract

FLASH radiotherapy (FLASH-RT) represents an innovative paradigm shift in radiation oncology. It is distinguished from conventional radiotherapy (CONV-RT) by the ultra-high dose rate (>40 Gy/s) radiation delivery to tumors within sub-millisecond bursts. Increasing preclinical studies have shown that FLASH-RT markedly reduces normal tissue toxicity without compromising antitumor efficacy, termed the "FLASH effect". Despite its potential, clinical implementation remains constrained by several challenges, including the incomplete understanding of its underlying biological mechanisms, the optimization of physical parameters, and ongoing technological hurdles. In this review, we systematically reviewed and synthesized the preclinical evidence across multiple organ systems, delineating the complex interplay of physical parameters that govern biological outcomes of FLASH-RT. Moving beyond phenomenological observations, this review provides a rigorous synthesis of mechanism ranging from initial physicochemical to biological processes, including transient oxygen depletion, radical recombination, differential DNA damage response, and mitochondrial reprogramming. A central focus is placed on the potent immunomodulatory role of FLASH-RT, highlighting its ability to preserve systemic immune competence and reshape the tumor immune microenvironment. These unique advantages have facilitated the initiation of FLASH-related clinical trials and position FLASH-RT as an exceptionally promising partner for next-generation immunotherapy, spatially fractionated approaches, and nanomedicine-based radio-sensitization research. While promising, mature clinical translation faces challenges. By synthesizing the interplay between ultra-high dose rate physics and molecular radiobiology, this review provides an integrated framework designed to translate fundamental FLASH effects into predictable and optimized therapeutic strategies for the next generation of precision cancer treatment.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Radiation Therapy and Dosimetry · Nanoplatforms for cancer theranostics · Effects of Radiation Exposure

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Radiotherapy toxicities: mechanisms, management, and future directions10.1016/S0140-6736(24)02319-5 ↗
2. Towards clinical translation of FLASH radiotherapy10.1038/s41571-022-00697-z ↗
3. Ultra-high dose rate (FLASH) radiotherapy: silver bullet or fool's gold?10.3389/fonc.2019.01563 ↗
4. Hypofractionated FLASH-RT as an effective treatment against glioblastoma that reduces neurocognitive side effects in mice10.1158/1078-0432.CCR-20-0894 ↗
5. FLASH radiotherapy: a new milestone in the field of cancer radiotherapy10.1016/j.canlet.2024.216651 ↗
6. Mechanisms, challenges and opportunities for FLASH radiotherapy in cancer10.1038/s41568-025-00878-9 ↗
7. Management of acute radiation dermatitis: a review of the literature and proposal for treatment algorithm10.1016/j.jaad.2019.02.047 ↗
8. Radiation-induced skin toxicity: prophylaxis or management?10.1002/jmrs.418 ↗
9. FLASH proton pencil beam scanning irradiation minimizes radiation-induced leg contracture and skin toxicity in mice10.3390/cancers13051012 ↗
10. The advantage of FLASH radiotherapy confirmed in mini-pig and cat-cancer patients10.1158/1078-0432.CCR-17-3375 ↗
11. Treatment of a first patient with FLASH-radiotherapy10.1016/j.radonc.2019.06.019 ↗
12. Proton FLASH: impact of dose rate and split dose on acute skin toxicity in a murine model10.1016/j.ijrobp.2024.04.071 ↗
13. Biological benefits of ultra-high dose rate FLASH radiotherapy: sleeping beauty awoken10.1016/j.clon.2019.04.001 ↗
14. FLASH irradiation results in reduced severe skin toxicity compared to conventional-dose-rate irradiation10.1667/RADE-20-00090 ↗
15. Electron vs proton FLASH radiation on murine skin toxicity10.1016/j.radonc.2025.110796 ↗
16. Radiation dose-dependent skin toxicity and therapeutic advantage of FLASH radiotherapy via immune modulation
17. Spread-out Bragg peak FLASH: quantifying normal tissue toxicity in a murine model10.3389/fonc.2024.1427667 ↗
18. In vivo validation and tissue sparing factor for acute damage of pencil beam scanning proton FLASH10.1016/j.radonc.2021.12.022 ↗
19. Dose, dose rate and split dose impacts murine skin responses following photon FLASH irradiation10.1016/j.radonc.2025.111125 ↗
20. Timescale of FLASH sparing effect determined by varying temporal split of dose delivery in mice10.1016/j.ijrobp.2025.09.052 ↗
21. Neurocognitive effects and necrosis in childhood cancer survivors treated with radiation therapy: a PENTEC comprehensive review10.1016/j.ijrobp.2020.11.073 ↗
22. Neurocognitive function after radiotherapy for paediatric brain tumours10.1038/nrneurol.2012.182 ↗
23. Change in neurocognitive functioning after treatment with cranial radiation in childhood10.1200/JCO.2004.05.186 ↗
24. Whole-brain irradiation and decline in intelligence: the influence of dose and age on IQ score10.1200/JCO.1992.10.9.1390 ↗
25. Long-term neurocognitive function after whole-brain radiotherapy in patients with melanoma brain metastases in the era of immunotherapy10.1007/s00066-022-01950-1 ↗
26. Strategies to preserve cognition in patients with brain metastases: a review10.3389/fonc.2018.00415 ↗
27. Memantine in the prevention of radiation-induced brain damage: a narrative review10.3390/cancers14112736 ↗
28. Long-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen species10.1073/pnas.1901777116 ↗
29. X-rays can trigger the FLASH effect: ultra-high dose-rate synchrotron light source prevents normal brain injury after whole brain irradiation in mice10.1016/j.radonc.2018.08.016 ↗
30. Neuroprotection of radiosensitive juvenile mice by ultra-high dose rate FLASH irradiation10.3390/cancers12061671 ↗
31. Elucidating the neurological mechanism of the FLASH effect in juvenile mice exposed to hypofractionated radiotherapy10.1093/neuonc/noac248 ↗
32. Immune response following FLASH and conventional radiation in diffuse midline glioma10.1016/j.ijrobp.2024.01.219 ↗
33. Reduced cognitive deficits after FLASH irradiation of whole mouse brain are associated with less hippocampal dendritic spine loss and neuroinflammation10.1016/j.radonc.2019.06.006 ↗
34. No differences in therapeutic efficacy while sparing healthy tissue for orthotopic glioblastoma patient-derived xenografts in context of proton FLASH
35. Uncovering the protective neurologic mechanisms of hypofractionated FLASH radiotherapy10.1158/2767-9764.CRC-23-0117 ↗
36. Six-month evaluation of normal mouse brain side effects: comparing FLASH and conventional proton partial brain irradiation
37. Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice10.1126/scitranslmed.3008973 ↗
38. FLASH irradiation spares lung progenitor cells and limits the incidence of radio-induced senescence10.1158/1078-0432.CCR-19-1440 ↗
39. Localized normal tissue-sparing effects of proton FLASH radiotherapy in a preclinical lung irradiation model10.1093/bjr/tqag015 ↗
40. Effects of ultra-high dose rate radiotherapy with different fractions and dose rate on acute and chronic lung injury in mice10.1016/j.heliyon.2024.e40298 ↗
41. Fractionated FLASH radiation in xenografted lung tumors induced FLASH effect at a split dose of 2 Gy10.1080/09553002.2023.2194403 ↗
42. FLASH radiotherapy mitigates radiation-induced lymphopenia and prevents immunosuppression via Chk1-STAT3 axis modulation in a preclinical thoracic irradiation model
43. Molecular mechanisms of lung injury from ultra high and conventional dose rate pulsed radiation based on 4D DIA proteomics study10.1038/s41598-025-87247-6 ↗
44. FLASH irradiation modulates immune responses and accelerates lung recovery: a single-cell perspective
45. FLASH irradiation-induced acute lung injury promotes metastatic colonization via neutrophil extracellular trap formation10.1002/mp.70054 ↗
46. Early inflammation and interferon signaling direct enhanced intestinal crypt regeneration after proton FLASH radiotherapy
47. Abdominal FLASH irradiation reduces radiation-induced gastrointestinal toxicity for the treatment of ovarian cancer in mice10.1038/s41598-020-78017-7 ↗
48. FLASH X-ray spares intestinal crypts from pyroptosis initiated by cGAS-STING activation upon radioimmunotherapy10.1073/pnas.2208506119 ↗
49. Radioprotective effect of X-ray abdominal FLASH irradiation: adaptation to oxidative damage and inflammatory response may be benefiting factors10.1002/mp.15680 ↗
50. Ultra high dose rate (35 Gy/sec) radiation does not spare the normal tissue in cardiac and splenic models of lymphopenia and gastrointestinal syndrome10.1038/s41598-019-53562-y ↗
51. Whole abdominal pencil beam scanned proton FLASH increases acute lethality10.1016/j.ijrobp.2024.09.006 ↗
52. Absence of tissue-sparing effects in partial proton FLASH irradiation in murine intestine10.3390/cancers15082269 ↗
53. Discordance in acute gastrointestinal toxicity between synchrotron-based proton and linac-based electron ultra-high dose rate irradiation10.1016/j.ijrobp.2025.01.007 ↗
54. Proton FLASH exposure preserves gut commensal microbiomes and spares intestinal stem cells
55. Redefining FLASH radiation therapy: the impact of mean dose rate and dose per pulse in the gastrointestinal tract10.1016/j.ijrobp.2024.10.009 ↗
56. Irradiation at ultra-high (FLASH) dose rates reduces acute normal tissue toxicity in the mouse gastrointestinal system10.1016/j.ijrobp.2021.08.004 ↗
57. Proton FLASH radiotherapy ameliorates radiation-induced salivary gland dysfunction and oral mucositis and increases survival in a mouse model of head and neck cancer10.1158/1535-7163.MCT-23-0663 ↗
58. FLASH proton radiation therapy mitigates inflammatory and fibrotic pathways and preserves cardiac function in a preclinical mouse model of radiation-induced heart disease10.1016/j.ijrobp.2024.01.224 ↗
59. Photon FLASH spares radiation-induced changes in cardiac function, remodelling and arrythmia in a preclinical model10.1016/j.radonc.2026.111369 ↗
60. FLASH proton reirradiation, with or without hypofractionation, reduces chronic toxicity in the normal murine intestine, skin, and bone10.1016/j.radonc.2025.110744 ↗
61. Feasibility of proton FLASH effect tested by zebrafish embryo irradiation10.1016/j.radonc.2019.06.024 ↗
62. Comparative toxicity of synchrotron and conventional radiation therapy based on total and partial body irradiation in a murine model10.1038/s41598-018-30543-1 ↗
63. Comparison of gonadal toxicity of single-fraction ultra-high dose rate and conventional radiation in mice
64. Clinical translation of FLASH radiotherapy: why and how?10.1016/j.radonc.2019.04.008 ↗
65. High dose-per-pulse electron beam dosimetry: commissioning of the Oriatron eRT6 prototype linear accelerator for preclinical use10.1002/mp.12713 ↗
66. FLASH radiotherapy: considerations for multibeam and hypofractionation dose delivery10.1016/j.radonc.2021.09.011 ↗
67. Bringing FLASH to the clinic: Treatment planning considerations for ultrahigh dose-rate proton beams10.1016/j.ijrobp.2019.11.011 ↗
68. Irradiation in a flash: unique sparing of memory in mice after whole brain irradiation with dose rates above 100Gy/s10.1016/j.radonc.2017.05.003 ↗
69. Dose and dose rate dependence of the tissue sparing effect at ultra-high dose rate studied for proton and electron beams using the zebrafish embryo model10.1016/j.radonc.2024.110197 ↗
70. FLASH irradiation induces lower levels of DNA damage ex vivo, an effect modulated by oxygen tension, dose, and dose rate10.1259/bjr.20211150 ↗
71. Mean dose rate in ultra-high dose rate electron irradiation is a significant predictor for O(2)consumption and H(2)O(2)yield10.1088/1361-6560/ace877 ↗
72. Analysis of hydrogen peroxide production in pure water: ultrahigh versus conventional dose-rate irradiation and mechanistic insights10.1002/mp.17335 ↗
73. Beam pulse structure and dose rate as determinants for the flash effect observed in zebrafish embryo10.1016/j.radonc.2022.05.025 ↗
74. Average dose rate is the major temporal beam structure parameter for preserving murine intestines with pulsed electron FLASH radiation therapy10.1016/j.ijrobp.2025.04.021 ↗
75. Changes in radical levels as a cause for the FLASH effect: impact of beam structure parameters at ultra-high dose rates on oxygen depletion in water10.1016/j.radonc.2022.08.024 ↗
76. Hydrated electron yield dependence on instantaneous dose rates with electron ultra-high dose rate (UHDR) irradiation10.1088/1361-6560/ade223 ↗
77. Dose rate effects on hydrated electrons, hydrogen peroxide, and a OH radical molecular probe under clinical energy protons10.1667/RADE-23-00244.1 ↗
78. Dosimetric and temporal beam characterization of individual pulses in FLASH radiotherapy using Timepix3 pixelated detector placed out-of-field10.1016/j.ejmp.2024.104872 ↗
79. Impact of multiple beams on the FLASH effect in soft tissue and skin in mice10.1016/j.ijrobp.2023.07.024 ↗
80. All irradiations that are ultra-high dose rate may not be FLASH: the critical importance of beam parameter characterization and in vivo validation of the FLASH effect10.1667/RADE-20-00141.1 ↗
81. Ultra-high-dose-rate FLASH irradiation limits reactive gliosis in the brain10.1667/RADE-20-00067.1 ↗
82. The sparing effect of FLASH-RT on synaptic plasticity is maintained in mice with standard fractionation10.1016/j.radonc.2023.109767 ↗
83. Decrease in dose per fraction impairs the FLASH sparing effect in murine intestine model
84. FLASH radiotherapy using single-energy proton PBS transmission beams for hypofractionation liver cancer: dose and dose rate quantification
85. Dose- and volume-limiting late toxicity of FLASH radiotherapy in cats with squamous cell carcinoma of the nasal planum and in mini pigs10.1158/1078-0432.CCR-22-0262 ↗
86. Ultra-high dose rate electron beams and the FLASH effect: from preclinical evidence to a new radiotherapy paradigm10.1002/mp.15442 ↗
87. Abdominopelvic FLASH irradiation improves PD-1 immune checkpoint inhibition in preclinical models of ovarian cancer10.1158/1535-7163.MCT-21-0358 ↗
88. Comparison of ultra-high versus conventional dose rate radiotherapy in a patient with cutaneous lymphoma10.1016/j.radonc.2021.12.045 ↗
89. Long-term toxicity and efficacy of FLASH radiotherapy in dogs with superficial malignant tumors10.3389/fonc.2024.1425240 ↗
90. VHEE FLASH sparing effect measured at CLEAR, CERN with DNA damage of pBR322 plasmid as a biological endpoint10.1038/s41598-024-65055-8 ↗
91. CERN-based experiments and Monte-Carlo studies on focused dose delivery with very high energy electron (VHEE) beams for radiotherapy applications10.1038/s41598-024-60997-5 ↗
92. Focused VHEE (very high energy electron) beams and dose delivery for radiotherapy applications10.1038/s41598-021-93276-8 ↗
93. FLASH radiotherapy with photon beams10.1002/mp.15222 ↗
94. Megavoltage photon FLASH for preclinical experiments10.1002/mp.17891 ↗
95. First demonstration of the FLASH effect with ultrahigh dose rate high-energy X-rays10.1016/j.radonc.2021.11.004 ↗
96. Dosimetric characterization of a novel UHDR megavoltage X-ray source for FLASH radiobiological experiments10.1038/s41598-023-50412-w ↗
97. Respiratory-gated micro-computed tomography imaging to measure radiation-induced lung injuries in mice following ultra-high dose-rate and conventional dose-rate radiation therapy10.1117/1.JMI.12.1.014002 ↗
98. FLASH radiotherapy: current knowledge and future insights using proton-beam therapy10.3390/ijms21186492 ↗
99. The importance and clinical implications of FLASH ultra-high dose-rate studies for proton and heavy ion radiotherapy10.1667/RR15537.1 ↗
100. Biological effects in normal cells exposed to FLASH dose rate protons10.1016/j.radonc.2019.02.009 ↗